RVMD
USDRevolution Medicines Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$57.990
고가
$59.680
저가
$57.740
거래량
2.37M
기업 기본 정보
시가총액
10.9B
산업
생명공학
국가
United States
거래 통계
평균 거래량
2.19M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
RBC Capital Initiates Coverage On Revolution Medicines with Outperform Rating, Announces Price Target of $77
RBC Capital analyst Leonid Timashev initiates coverage on Revolution Medicines with a Outperform rating and announces Price Target of $77.
Revolution Medicines' RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer
REDWOOD CITY, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
REDWOOD CITY, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today
Mizuho Initiates Coverage On Revolution Medicines with Outperform Rating, Announces Price Target of $90
Mizuho analyst Joseph Catanzaro initiates coverage on Revolution Medicines with a Outperform rating and announces Price Target of $90.
